NYSE ARCA | ETF
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy.
It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index.
The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 3.04% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 2.94% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.92% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.88% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 2.67% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 2.43% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 2.42% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.41% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 2.37% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 2.37% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.34% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.34% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 2.32% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.21% |
| MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 2.20% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 2.08% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 1.96% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.94% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 1.81% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 1.76% |